Report Detail
Global Pneumococcal Vaccines Market Insights and Forecast to 2026
- RnM4166236 |
- 26 August, 2020 |
- Global |
- 145 Pages |
- QYResearch |
- Pharma & Healthcare
Pneumococcal Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pneumococcal Vaccines market is segmented into
PPSV 23
PCV 7/13
PCV 10
Segment by Application, the Pneumococcal Vaccines market is segmented into
For Infants
For Children (2-10)
For Person (10-64)
For The Old (Above 65)
Regional and Country-level Analysis
The Pneumococcal Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pneumococcal Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pneumococcal Vaccines Market Share Analysis
Pneumococcal Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Vaccines business, the date to enter into the Pneumococcal Vaccines market, Pneumococcal Vaccines product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
1 Study Coverage
- 1.1 Pneumococcal Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key Pneumococcal Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Type
- 1.4.2 PPSV 23
- 1.4.3 PCV 7/13
- 1.4.4 PCV 10
- 1.5 Market by Application
- 1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by Application
- 1.5.2 For Infants
- 1.5.3 For Children (2-10)
- 1.5.4 For Person (10-64)
- 1.5.5 For The Old (Above 65)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pneumococcal Vaccines Market Size, Estimates and Forecasts
- 2.1.1 Global Pneumococcal Vaccines Revenue 2015-2026
- 2.1.2 Global Pneumococcal Vaccines Sales 2015-2026
- 2.2 Global Pneumococcal Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Pneumococcal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Pneumococcal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pneumococcal Vaccines Competitor Landscape by Players
- 3.1 Pneumococcal Vaccines Sales by Manufacturers
- 3.1.1 Pneumococcal Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 Pneumococcal Vaccines Revenue by Manufacturers
- 3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Pneumococcal Vaccines Revenue in 2019
- 3.2.5 Global Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Pneumococcal Vaccines Price by Manufacturers
- 3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pneumococcal Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Pneumococcal Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global Pneumococcal Vaccines Sales by Type (2015-2020)
- 4.1.2 Global Pneumococcal Vaccines Revenue by Type (2015-2020)
- 4.1.3 Pneumococcal Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Pneumococcal Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Pneumococcal Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global Pneumococcal Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 Pneumococcal Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Pneumococcal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Pneumococcal Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global Pneumococcal Vaccines Sales by Application (2015-2020)
- 5.1.2 Global Pneumococcal Vaccines Revenue by Application (2015-2020)
- 5.1.3 Pneumococcal Vaccines Price by Application (2015-2020)
- 5.2 Pneumococcal Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Pneumococcal Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global Pneumococcal Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Pneumococcal Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Pneumococcal Vaccines by Country
- 6.1.1 North America Pneumococcal Vaccines Sales by Country
- 6.1.2 North America Pneumococcal Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Pneumococcal Vaccines Market Facts & Figures by Type
- 6.3 North America Pneumococcal Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe Pneumococcal Vaccines by Country
- 7.1.1 Europe Pneumococcal Vaccines Sales by Country
- 7.1.2 Europe Pneumococcal Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pneumococcal Vaccines Market Facts & Figures by Type
- 7.3 Europe Pneumococcal Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Pneumococcal Vaccines by Region
- 8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Region
- 8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Pneumococcal Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific Pneumococcal Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Pneumococcal Vaccines by Country
- 9.1.1 Latin America Pneumococcal Vaccines Sales by Country
- 9.1.2 Latin America Pneumococcal Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Pneumococcal Vaccines Market Facts & Figures by Type
- 9.3 Central & South America Pneumococcal Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Pneumococcal Vaccines by Country
- 10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Country
- 10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Pneumococcal Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa Pneumococcal Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Pneumococcal Vaccines Products Offered
- 11.1.5 Pfizer Related Developments
- 11.2 Sanofi
- 11.2.1 Sanofi Corporation Information
- 11.2.2 Sanofi Description and Business Overview
- 11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Sanofi Pneumococcal Vaccines Products Offered
- 11.2.5 Sanofi Related Developments
- 11.3 GSK
- 11.3.1 GSK Corporation Information
- 11.3.2 GSK Description and Business Overview
- 11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 GSK Pneumococcal Vaccines Products Offered
- 11.3.5 GSK Related Developments
- 11.4 Merck
- 11.4.1 Merck Corporation Information
- 11.4.2 Merck Description and Business Overview
- 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Merck Pneumococcal Vaccines Products Offered
- 11.4.5 Merck Related Developments
- 11.5 Eli Lilly
- 11.5.1 Eli Lilly Corporation Information
- 11.5.2 Eli Lilly Description and Business Overview
- 11.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
- 11.5.5 Eli Lilly Related Developments
- 11.6 AstraZeneca
- 11.6.1 AstraZeneca Corporation Information
- 11.6.2 AstraZeneca Description and Business Overview
- 11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
- 11.6.5 AstraZeneca Related Developments
- 11.7 Abera
- 11.7.1 Abera Corporation Information
- 11.7.2 Abera Description and Business Overview
- 11.7.3 Abera Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Abera Pneumococcal Vaccines Products Offered
- 11.7.5 Abera Related Developments
- 11.8 S K Chemicals
- 11.8.1 S K Chemicals Corporation Information
- 11.8.2 S K Chemicals Description and Business Overview
- 11.8.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
- 11.8.5 S K Chemicals Related Developments
- 11.9 Beijing Minhai Biotechnology
- 11.9.1 Beijing Minhai Biotechnology Corporation Information
- 11.9.2 Beijing Minhai Biotechnology Description and Business Overview
- 11.9.3 Beijing Minhai Biotechnology Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
- 11.9.5 Beijing Minhai Biotechnology Related Developments
- 11.10 Baxter
- 11.10.1 Baxter Corporation Information
- 11.10.2 Baxter Description and Business Overview
- 11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Baxter Pneumococcal Vaccines Products Offered
- 11.10.5 Baxter Related Developments
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Pneumococcal Vaccines Products Offered
- 11.1.5 Pfizer Related Developments
- 11.12 Celgene Corporation
- 11.12.1 Celgene Corporation Corporation Information
- 11.12.2 Celgene Corporation Description and Business Overview
- 11.12.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Celgene Corporation Products Offered
- 11.12.5 Celgene Corporation Related Developments
- 11.13 Panacea Biotec
- 11.13.1 Panacea Biotec Corporation Information
- 11.13.2 Panacea Biotec Description and Business Overview
- 11.13.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Panacea Biotec Products Offered
- 11.13.5 Panacea Biotec Related Developments
- 11.14 Serum Institute of India
- 11.14.1 Serum Institute of India Corporation Information
- 11.14.2 Serum Institute of India Description and Business Overview
- 11.14.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Serum Institute of India Products Offered
- 11.14.5 Serum Institute of India Related Developments
- 11.15 Genentech
- 11.15.1 Genentech Corporation Information
- 11.15.2 Genentech Description and Business Overview
- 11.15.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Genentech Products Offered
- 11.15.5 Genentech Related Developments
- 11.16 Genocea Biosciences
- 11.16.1 Genocea Biosciences Corporation Information
- 11.16.2 Genocea Biosciences Description and Business Overview
- 11.16.3 Genocea Biosciences Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Genocea Biosciences Products Offered
- 11.16.5 Genocea Biosciences Related Developments
- 11.17 ImmunoBiology
- 11.17.1 ImmunoBiology Corporation Information
- 11.17.2 ImmunoBiology Description and Business Overview
- 11.17.3 ImmunoBiology Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 ImmunoBiology Products Offered
- 11.17.5 ImmunoBiology Related Developments
- 11.18 Lupin
- 11.18.1 Lupin Corporation Information
- 11.18.2 Lupin Description and Business Overview
- 11.18.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Lupin Products Offered
- 11.18.5 Lupin Related Developments
- 11.19 Nuron Biotech
- 11.19.1 Nuron Biotech Corporation Information
- 11.19.2 Nuron Biotech Description and Business Overview
- 11.19.3 Nuron Biotech Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Nuron Biotech Products Offered
- 11.19.5 Nuron Biotech Related Developments
- 11.20 Biogen
- 11.20.1 Biogen Corporation Information
- 11.20.2 Biogen Description and Business Overview
- 11.20.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Biogen Products Offered
- 11.20.5 Biogen Related Developments
- 11.21 Valneva Austria
- 11.21.1 Valneva Austria Corporation Information
- 11.21.2 Valneva Austria Description and Business Overview
- 11.21.3 Valneva Austria Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Valneva Austria Products Offered
- 11.21.5 Valneva Austria Related Developments
- 11.22 Sinovac
- 11.22.1 Sinovac Corporation Information
- 11.22.2 Sinovac Description and Business Overview
- 11.22.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
- 11.22.4 Sinovac Products Offered
- 11.22.5 Sinovac Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Pneumococcal Vaccines Market Estimates and Projections by Region
- 12.1.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America Pneumococcal Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: Pneumococcal Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: Pneumococcal Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe Pneumococcal Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: Pneumococcal Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: Pneumococcal Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Pneumococcal Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Pneumococcal Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Pneumococcal Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Pneumococcal Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Pneumococcal Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Pneumococcal Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: Pneumococcal Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Pneumococcal Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Pneumococcal Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Pneumococcal Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Pneumococcal Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pneumococcal Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pneumococcal Vaccines. Industry analysis & Market Report on Pneumococcal Vaccines is a syndicated market report, published as Global Pneumococcal Vaccines Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Pneumococcal Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
